VIP | Srmoreli Acetate (GHRH 1-29) Lyophilized Powder for Lab Research
TDS 3 Inquiries
40077-57-4
Pharmaceutical Grade
99%
HONGKONG
band
10 pieces per box
2027-12-01
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceVasoactive Intestinal Peptide Synthetic is a single, non-glycosylated polypeptide chain containing 28 amino acids, having a molecular mass of 3325 Dalton and a Molecular formula of C147H238N44O42S.Certificates
-
TDS
Basic Info-
Product Name:
Aviptadil
Other Name:VASOACTIVE INTESTINAL PEPTIDE (HUMAN, BOVINE, PORCINE, RAT);VASOACTIVE INTESTINAL PEPTIDE (HUMAN, PORCINE);VASOACTIVE INTESTINAL PEPTIDE, HUMAN, PORCINE, AND RAT;VASOACTIVE INTESTINAL PEPTIDE (HUMAN, PORCINE) (BOVINE, RAT, CANINE);VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RAT;VASOACTIVE INTESTINAL PEPTIDE, HUMAN, PORCINE, RAT, OVINE;VASOACTIVE INTESTINAL PEPTIDE, PORCINE;VIP, (HUMAN, PORCINE, RAT, OVINE)
CAS No.:40077-57-4
Molecular Formula:C147H238N44O42S
InChIKeys:HEOYHMUESMJFDC-RIWXPGAOSA-N
Molecular Weight:3325.8
EC Number:200-001-8
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.47±0.1 g/cm3(Predicted)
Water Solubility:Soluble to 1 mg/ml in water
Critical Temperature & Pressure:−20°C
Research-
Class:
GHRH analog (1–29 amino-terminal fragment, 29-amino-acid peptide amide)
Status:FDA-approved diagnostic agent (Geref, discontinued). NOT for therapeutic use.
Mechanism:A synthetic 29-amino-acid peptide (H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂) identical to the amino-terminal segment of endogenous human GHRH. Sermorelin binds to the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, stimulating pulsatile GH synthesis and secretion via the cAMP/PKA pathway. Unlike exogenous GH, sermorelin preserves the endogenous GH pulsatility and IGF-1 feedback loop.
EC50 (Ghrhr Ec50):~0.1–1 nM (cAMP accumulation in rat pituitary cells)
Source:DrugBank: DB00010. Frohman LA, et al. Endocr Rev. 1986;7(3):223–253.DOI
Clinical Development:FDA:Geref (approved 1991-10-11)
References-
ChEMBL:
CHEMBL1201555
DrugBank:KEGG DRUG:D08554
PubChem:Literature:Disclaimer:Sermorelin was FDA-approved as a diagnostic agent (Geref) for growth hormone deficiency but has been discontinued (not for safety reasons). It is NOT approved for anti-aging, bodybuilding, or therapeutic GH replacement. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Location:
RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG
-
Year of Establishment:
2026
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
United States
Aviptadil
1 G Oct 26, 2024
India
Aviptadil Acetate
300 G Aug 21, 2023
United States
Aviptadil
1 G Oct 25, 2024 Post an enquiry for this product